Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | MAOA | P21397 | 1/20 | 0.49 |
| ▸ | MAOB | P27338 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | CA1 | P00915 | 7/20 | 0.47 |
| ▸ | CA2 | P00918 | 7/20 | 0.47 |
| ▸ | CA12 | O43570 | 6/20 | 0.47 |
| ▸ | CA9 | Q16790 | 6/20 | 0.47 |
| ▸ | TPSAB1 | Q15661 | 1/20 | 0.44 |
| ▸ | TPSD1 | Q9BZJ3 | 1/20 | 0.44 |
| ▸ | TPSG1 | Q9NRR2 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.41 |
| ▸ | DRD2 | P14416 | 1/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.38 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.38 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14742742 | 0.95 | TDP1 (0.53) | TDP1MAOAMAOBMEN1GAA | |
| SCHEMBL14742682 | 0.89 | TDP1 (0.47) | TDP1MAOAMAOBMEN1GAA | |
| SCHEMBL22175551 | 0.84 | TSHR (0.55) | TDP1MAOAMAOBMEN1GAA | |
| SCHEMBL16349624 | 0.84 | TDP1 (0.66) | TDP1MAOAMAOBMEN1GAA | |
| SCHEMBL14742530 | 0.82 | TDP1 (0.42) | TDP1MAOAMAOBMEN1GAA | |
| SCHEMBL25942884 | 0.82 | TDP1 (0.69) | TDP1MAOAMAOBMEN1GAA | |
| SCHEMBL15373104 | 0.82 | TDP1 (0.64) | TDP1MAOAMAOBMEN1GAA | |
| SCHEMBL25092096 | 0.81 | TDP1 (0.67) | TDP1MAOAMAOBMEN1GAA | |
| SCHEMBL22276612 | 0.81 | TDP1 (0.67) | TDP1MAOAMAOBMEN1GAA | |
| SCHEMBL22276594 | 0.81 | TDP1 (0.67) | TDP1MAOAMAOBMEN1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9474804-B2 | Poly(vinyl ester) polymers for in vivo nucleic acid delivery | Arrowhead Pharmaceuticals, Inc. (US) | 2016-10-25 | — | — | US | disclosed |
| US-9474804-B2 | Poly(vinyl ester) polymers for in vivo nucleic acid delivery | Arrowhead Pharmaceuticals, Inc. (US) | 2016-10-25 | — | — | US | disclosed |
| US-9474804-B2 | Poly(vinyl ester) polymers for in vivo nucleic acid delivery | Arrowhead Pharmaceuticals, Inc. (US) | 2016-10-25 | — | — | US | disclosed |
| US-20150283256-A1 | Poly(vinyl ester) Polymers for In Vivo Nucleic Acid Delivery | Arrowhead Pharmaceuticals, Inc. | 2015-10-08 | — | — | US | disclosed |
| US-20150283256-A1 | Poly(vinyl ester) Polymers for In Vivo Nucleic Acid Delivery | Arrowhead Pharmaceuticals, Inc. | 2015-10-08 | — | — | US | disclosed |
| US-20150283256-A1 | Poly(vinyl ester) Polymers for In Vivo Nucleic Acid Delivery | Arrowhead Pharmaceuticals, Inc. | 2015-10-08 | — | — | US | disclosed |
| US-9089611-B2 | Poly(vinyl ester) polymers for in vivo nucleic acid delivery | Arrowhead Madison Inc. (US) | 2015-07-28 | — | — | US | disclosed |
| US-9089611-B2 | Poly(vinyl ester) polymers for in vivo nucleic acid delivery | Arrowhead Madison Inc. (US) | 2015-07-28 | — | — | US | disclosed |
| US-9089611-B2 | Poly(vinyl ester) polymers for in vivo nucleic acid delivery | Arrowhead Madison Inc. (US) | 2015-07-28 | — | — | US | disclosed |
| US-20150110732-A1 | Poly(vinyl ester) Polymers for In Vivo Nucleic Acid Delivery | Arrowhead Madison Inc. | 2015-04-23 | — | — | US | disclosed |
| US-20150110732-A1 | Poly(vinyl ester) Polymers for In Vivo Nucleic Acid Delivery | Arrowhead Madison Inc. | 2015-04-23 | — | — | US | disclosed |
| US-8932572-B2 | Poly(vinyl ester) polymers for in vivo nucleic acid delivery | Arrowhead Madison Inc. (US) | 2015-01-13 | — | — | US | disclosed |
| US-8932572-B2 | Poly(vinyl ester) polymers for in vivo nucleic acid delivery | Arrowhead Madison Inc. (US) | 2015-01-13 | — | — | US | disclosed |
| US-8932572-B2 | Poly(vinyl ester) polymers for in vivo nucleic acid delivery | Arrowhead Madison Inc. (US) | 2015-01-13 | — | — | US | disclosed |
| EP-2807216-A1 | POLY(VINYL ESTER) POLYMERS FOR IN VIVO NUCLEIC ACID DELIVERY | Arrowhead Research Corporation (US) | 2014-12-03 | — | — | EP | disclosed |
| US-20130121954-A1 | Poly(vinyl ester) Polymers for In Vivo Nucleic Acid Delivery | Arrowhead Madison Inc. (US) | 2013-05-16 | — | — | US | disclosed |
| US-20130121954-A1 | Poly(vinyl ester) Polymers for In Vivo Nucleic Acid Delivery | Arrowhead Madison Inc. (US) | 2013-05-16 | — | — | US | disclosed |
| US-20130121954-A1 | Poly(vinyl ester) Polymers for In Vivo Nucleic Acid Delivery | Arrowhead Madison Inc. (US) | 2013-05-16 | — | — | US | disclosed |
| WO-2013032829-A1 | POLY(VINYL ESTER) POLYMERS FOR IN VIVO NUCLEIC ACID DELIVERY | ARROWHEAD RESEARCH CORPORATION (US) | 2013-03-07 | — | — | WO | disclosed |
| WO-2013032829-A1 | POLY(VINYL ESTER) POLYMERS FOR IN VIVO NUCLEIC ACID DELIVERY | ARROWHEAD RESEARCH CORPORATION (US) | 2013-03-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150283256-A1 | Poly(vinyl ester) Polymers for In Vivo Nucleic Acid Delivery | PHAX, PARG, PABPC4 | TDP1 1165/4885MAOA 4752/4885MAOB 4751/4885 |
| US-20150110732-A1 | Poly(vinyl ester) Polymers for In Vivo Nucleic Acid Delivery | PHAX, PARG, PABPC4 | TDP1 1165/4885MAOA 4752/4885MAOB 4751/4885 |
| US-20130121954-A1 | Poly(vinyl ester) Polymers for In Vivo Nucleic Acid Delivery | PHAX, PARG, PABPC4 | TDP1 1165/4885MAOA 4752/4885MAOB 4751/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.